bloali
Lv2
130 积分
2023-10-11 加入
-
The L‐α‐Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis
24天前
已关闭
-
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
3个月前
已完结
-
Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways
3个月前
已完结
-
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
4个月前
已完结
-
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
4个月前
已完结
-
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
4个月前
已完结
-
AMPK and the Endocrine Control of Metabolism
5个月前
已完结
-
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
6个月前
已完结
-
Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
7个月前
已完结